Cargando…
First person – Omkara Lakshmi Veeranki
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Omkara Lakshmi Veeranki is first author on ‘ A novel patient-derived orthotopic xenograft m...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918780/ http://dx.doi.org/10.1242/dmm.043521 |
_version_ | 1783480658853625856 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Omkara Lakshmi Veeranki is first author on ‘ A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries’, published in DMM. Omkara Lakshmi is a postdoctoral fellow in the lab of Dr Dipen Maru at The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The focus of her research is understanding key molecular targets and the alterations in gene expression that contribute to pathogenesis of gastrointestinal cancers, which could be used for developing anticancer therapeutics. |
format | Online Article Text |
id | pubmed-6918780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-69187802019-12-24 First person – Omkara Lakshmi Veeranki Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Omkara Lakshmi Veeranki is first author on ‘ A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries’, published in DMM. Omkara Lakshmi is a postdoctoral fellow in the lab of Dr Dipen Maru at The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The focus of her research is understanding key molecular targets and the alterations in gene expression that contribute to pathogenesis of gastrointestinal cancers, which could be used for developing anticancer therapeutics. The Company of Biologists Ltd 2019-12-17 /pmc/articles/PMC6918780/ http://dx.doi.org/10.1242/dmm.043521 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Omkara Lakshmi Veeranki |
title | First person – Omkara Lakshmi Veeranki |
title_full | First person – Omkara Lakshmi Veeranki |
title_fullStr | First person – Omkara Lakshmi Veeranki |
title_full_unstemmed | First person – Omkara Lakshmi Veeranki |
title_short | First person – Omkara Lakshmi Veeranki |
title_sort | first person – omkara lakshmi veeranki |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918780/ http://dx.doi.org/10.1242/dmm.043521 |